Klüver-Bucy syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:157823G04.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Klüver-Bucy syndrome (KBS) is a rare neurological disorder resulting from bilateral damage to the temporal lobes of the brain, particularly the amygdalae and surrounding structures. It was first described in rhesus monkeys following bilateral temporal lobectomy and later recognized in humans. The syndrome is not a genetic condition but rather an acquired disorder caused by various underlying conditions, including herpes simplex encephalitis, traumatic brain injury, stroke, Alzheimer's disease, frontotemporal dementia, and other encephalitic or neurodegenerative processes. The syndrome primarily affects the central nervous system and is characterized by a distinctive constellation of behavioral and cognitive symptoms. Key clinical features include hyperorality (a compulsive tendency to examine objects by mouth), visual agnosia (inability to recognize objects or faces), placidity or flattened emotional responses, hypermetamorphosis (an irresistible impulse to react to and explore every visual stimulus), altered dietary habits (including attempts to eat inappropriate objects), and changes in sexual behavior (often hypersexuality or inappropriate sexual conduct). Memory disturbances, particularly amnesia, are also commonly observed. The full syndrome with all classic features is rare in humans; partial forms presenting with only some of these symptoms are more frequently encountered. Treatment of Klüver-Bucy syndrome is primarily directed at the underlying cause and is largely supportive. There is no specific cure for the syndrome itself. Management may include pharmacological interventions such as anticonvulsants (e.g., carbamazepine), selective serotonin reuptake inhibitors (SSRIs), or antipsychotic medications to help manage behavioral disturbances. Behavioral therapy and a structured, safe environment are important components of care. Prognosis varies considerably depending on the underlying etiology; cases caused by encephalitis or trauma may show partial recovery over time, while those associated with progressive neurodegenerative diseases tend to worsen.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Klüver-Bucy syndrome.

View clinical trials →

No actively recruiting trials found for Klüver-Bucy syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Klüver-Bucy syndrome community →

No specialists are currently listed for Klüver-Bucy syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Klüver-Bucy syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Klüver-Bucy syndromeForum →

No community posts yet. Be the first to share your experience with Klüver-Bucy syndrome.

Start the conversation →

Latest news about Klüver-Bucy syndrome

No recent news articles for Klüver-Bucy syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Klüver-Bucy syndrome

What is Klüver-Bucy syndrome?

Klüver-Bucy syndrome (KBS) is a rare neurological disorder resulting from bilateral damage to the temporal lobes of the brain, particularly the amygdalae and surrounding structures. It was first described in rhesus monkeys following bilateral temporal lobectomy and later recognized in humans. The syndrome is not a genetic condition but rather an acquired disorder caused by various underlying conditions, including herpes simplex encephalitis, traumatic brain injury, stroke, Alzheimer's disease, frontotemporal dementia, and other encephalitic or neurodegenerative processes. The syndrome primari

How is Klüver-Bucy syndrome inherited?

Klüver-Bucy syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.